Yacine brings a strong background in Market Access, Pricing and U.S. Managed Markets including extensive payer, access, pricing and reimbursement capabilities. Yacine has led engagements across multiple therapeutic areas both in the U.S and overseas for leading pharma players as well as biotech firms. His Market Access and Pricing experience spans from clinical evidence and value proposition development to pricing & reimbursement strategy, global pricing policy development, and Oncology access strategy. Outside Market Access and pricing, he has led engagements in due diligence, landscape assessments, opportunity assessments, pipeline strategy and more.
“I am thrilled to add Yacine to our growing team. His impressive background in Managed Markets adds a vital and complementary offering to the broader Deallus portfolio and combines nicely with our core strategic intelligence capabilities, allowing us to partner with clients across functions in order to help them win in the market.”
Peter Hempshall, CEO
“Deallus is a very active place, powered by a pool of highly motivated and intelligent consultants with a strong scientific basis. I look forward to sharing my research and US/Global consulting experience with my new colleagues to expand our offerings in the value, pricing and access space for our pharma and biotech clients alike.”